The effects of probiotics and synbiotic supplementation on glucose and insulin metabolism in adults with prediabetes: a double-blind randomized clinical trial

Acta Diabetologica

Volumn 55, Issue 10, 2018, Pages 1019-1028

  Kassaian, Nazila ^a   Feizi, Awat ^a   Aminorroaya, Ashraf ^a   Jafari, Parvaneh ^b   Ebrahimi, Maryam Tajabadi ^c   Amini, Masoud ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Clinical trial; Prediabetes; Probiotics; Synbiotic

Indexed keywords

BIOLOGICAL MARKER; HEMOGLOBIN A1C; INSULIN; PLACEBO; PROBIOTIC AGENT; SYNBIOTIC AGENT; GLYCOSYLATED HEMOGLOBIN; INSULIN DERIVATIVE;

ADULT; ANTHROPOMETRY; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DYSPEPSIA; DYSPHAGIA; FASTING; FEMALE; FLATULENCE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HOMEOSTASIS MODEL ASSESSMENT; HOMEOSTATIC MODEL ASSESSMENT OF BETA CELL FUNCTION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN LEVEL; INSULIN METABOLISM; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PARALLEL DESIGN; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; AGED; ANALYSIS; DIET RESTRICTION; DIETARY SUPPLEMENT; INSULIN RESISTANCE; IRAN; METABOLISM;

ADULT; AGED; BIOMARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FASTING; FEMALE; GLYCATED HEMOGLOBIN A; HUMANS; INSULIN RESISTANCE; INSULINS; IRAN; MALE; MIDDLE AGED; PREDIABETIC STATE; PROBIOTICS; SYNBIOTICS;

EID: 85048834970     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-018-1175-2     Document Type: Article

References (38)

1. Rokana N, Duary RK, Panwar H, Batish VK, Grover S (2012) Management of metabolic syndrome through probiotic and prebiotic interventions. Indian J Endocrinol Metab 16(1):20–27
2. Daniele G, Abdul-Ghani M, DeFronzo RA (2014) What are the pharmacotherapy options for treating prediabetes? Expert Opin Pharmacother 15(14):2003–2018
3. Bansal N (2015) Prediabetes diagnosis and treatment: a review. World J Diabetes 6(2):296–303
4. He M, Shi B (2017) Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics. Cell Biosci 7:54
5. Sato J, Kanazawa A, Watada H (2017) Type 2 diabetes and bacteremia. Ann Nutr Metab 71(Suppl 1):17–22
6. Upadhyaya S, Banerjee G (2015) Type 2 diabetes and gut microbiome: at the intersection of known and unknown. Gut Microbes 6(2):85–92
7. Hulston CJ, Churnside AA, Venables MC (2015) Probiotic supplementation prevents high-fat, overfeeding-induced insulin resistance in human subjects. Br J Nutr 113(4):596–602
8. Sáez-Lara MJ, Robles-Sanchez C, Ruiz-Ojeda FJ, Plaza-Diaz J, Gil A (2016) Effects of probiotics and synbiotics on obesity, insulin resistance syndrome, type 2 diabetes and non-alcoholic fatty liver disease: a review of human clinical trials. Int J Mol Sci 17(6):928
9. Louis P, Flint HJ, Michel C (2016) How to manipulate the microbiota: prebiotics. Adv Exp Med Biol 902:119–142
10. de Vrese M, Schrezenmeir J (2008) Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol 111:1–66
11. Marchesi JR, Adams DH, Fava F, Hermes GD, Hirschfield GM, Hold G et al (2016) The gut microbiota and host health: a new clinical frontier. Gut 65(2):330–339
12. Guiné RPF, Silva ACF (2017) Probiotics, Prebiotics and synbiotics. In: Nelson DL (ed) Functional foods: sources, health effects and future perspectives. Chapter 5. Nova Publishers, New York, 143–207
13. Poppitt S (2017) Hyperglycaemia, pre-diabetes and diabesity: can we choose who to ‘fast-track’into diabetes prevention? Curr Res Diabetes Obes J 2(3):1–3
14. Pandis N, Chung B, Scherrer R, Elbourne D, Altman D (2017) CONSORT extension for reporting within-person randomised trials. BMJ 357:1–22
15. Eslamparast T, Zamani F, Hekmatdoost A, Sharafkhah M, Eghtesad S, Malekzadeh R et al (2014) Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study. Br J Nutr 112(3):438–445
16. Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412–419
17. Hřebíček J, Janout V, Malinčíková J, Horáková D, Čížek L (2002) Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab 87(1):144
18. Mossavar-Rahmani Y (2017) Reducing measurement error in nutrition assessment: potential research implications for Iran. Nutr Food Sci Res 4(1):3–10
19. Strath SJ, Kaminsky LA, Ainsworth BE, Ekelund U, Freedson PS, Gary RA et al (2013) Guide to the assessment of physical activity: clinical and research applications. Circulation 128(20):2259–2279
20. Yao K, Zeng L, He Q, Wang W, Lei J, Zou X (2017) Effect of probiotics on glucose and lipid metabolism in type 2 diabetes mellitus: a meta-analysis of 12 randomized controlled trials. Med Sci Monit 23:3044–3053
21. Festi D, Schiumerini R, Eusebi LH, Marasco G, Taddia M, Colecchia A (2014) Gut microbiota and metabolic syndrome. World J Gastroenterol WJG 20(43):16079
22. Abrams SA, Griffin IJ, Hawthorne KM, Ellis KJ (2007) Effect of prebiotic supplementation and calcium intake on body mass index. J Pediatr 151(3):293–298
23. Pedersen C, Lefevre S, Peters V, Patterson M, Ghatei MA, Morgan LM et al (2013) Gut hormone release and appetite regulation in healthy non-obese participants following oligofructose intake. A dose-escalation study. Appetite 66:44–53
24. Franz MJ, VanWormer JJ, Crain AL, Boucher JL, Histon T, Caplan W et al (2007) Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc 107(10):1755–1767
25. Taghizadeh M, Asemi Z (2014) Effects of synbiotic food consumption on glycemic status and serum hs-CRP in pregnant women: a randomized controlled clinical trial. Hormones 13(3):398–406
26. Tabrizi R, Moosazadeh M, Lankarani KB, Akbari M, Heydari ST, Kolahdooz F et al (2017) The effects of synbiotic supplementation on glucose metabolism and lipid profiles in patients with diabetes: a systematic review and meta-analysis of randomized controlled trials. Probiot Antimicrob Proteins. 10.1007/s12602-017-9299-1
27. Triplot N, Leber B, Blattl D (2012) Effect of supplementation with Lactobacillus casei Shirota on insulin sensitivity, b-cell function, and markers of endothelial function and inflammation in subjects with the metabolic syndrome—a pilot study. J Dairy Sci 96:89–95
28. Barazzoni R, Deutz N, Biolo G, Bischoff S, Boirie Y, Cederholm T et al (2017) Carbohydrates and insulin resistance in clinical nutrition: recommendations from the ESPEN expert group. Clin Nutr 36(2):355–363
29. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D et al (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56(7):1761–1772
30. Allin KH, Nielsen T, Pedersen O (2015) Mechanisms in endocrinology: gut microbiota in patients with type 2 diabetes mellitus. Eur J Endocrinol 172(4):R167–R177
31. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM et al (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57(6):1470–1481
32. Cani PD, Possemiers S, Van de Wiele T, Guiot Y, Everard A, Rottier O et al(2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58(8):1091–1103
33. Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M et al (2009) Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58(7):1509–1517
34. Lin HV, Frassetto A, Kowalik EJ Jr, Nawrocki AR, Lu MM, Kosinski JR et al (2012) Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PloS One 7(4):e35240
35. Wichmann A, Allahyar A, Greiner TU, Plovier H, Lundén G, Larsson T et al (2013) Microbial modulation of energy availability in the colon regulates intestinal transit. Cell Host Microbe 14(5):582–590
36. Russo F, Riezzo G, Chiloiro M, De Michele G, Chimienti G, Marconi E et al (2010) Metabolic effects of a diet with inulin-enriched pasta in healthy young volunteers. Curr Pharm Des 16(7):825–831
37. Kim Y, Keogh J, Clifton P (2017) Probiotics, prebiotics, synbiotics and insulin sensitivity. Nutr Res Rev 17:1–17
38. Tolhurst G, Heffron H, Lam YS, Parker HE, Habib AM, Diakogiannaki E et al (2012) Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61(2):364–371